Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 43 results.
User Information
Export Records
  1. 1.   Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis-a case report
  2. Gooding,Megan; Hammoud, Dima A; Epling, Brian; Rocco, Joseph; Laidlaw, Elizabeth; Kuriakose,Safia; Chaturvedi, Mansi; Galindo, Frances; Ma, Stella V; Mystakelis, Harry; Poole, April; Russo, Kelly; Shah, Maunank; Malone, Joseph L; Rupert,Adam; Sereti, Irini; Manion, Maura
  3. Frontiers in Immunology. 2024, Oct 31; 15: 1441945.
  1. 2.   Newkome-Type Dendron-Stabilized Gold Nanoparticles: Synthesis, Reactivity, and Stability
  2. Cho, T. J.; Zangmeister, R. A.; MacCuspie, R. I.; Patri, A. K.; Hackley, V. A.
  3. Chemistry of Materials. 2011, May; 23(10): 2665-2676.
  1. 3.   Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
  2. He, Y. P.; Long, J.; Zhang, S. S.; Li, C.; Lai, C. C.; Zhang, C. S.; Li, D. X.; Zhang, D. H.; Wang, H.; Cai, Q. Q.; Zheng, Y. T.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jan; 21(2): 694-697.
  1. 4.   Synthesis and biological activity of 5-aza-ellipticine derivatives
  2. Moody, D. L.; Dyba, M.; Kosakowska-Cholody, T.; Tarasova, N. I.; Michejda, C. I.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Apr; 17(8): 2380-2384.
  1. 5.   Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry
  2. Xu, X.; Roman, J. M.; Veenstra, T. D.; Van Anda, J.; Ziegler, R. G.; Issaq, H. J.
  3. Analytical Chemistry. 2006, MAR 1; 78(5): 1553-1558.
  1. 6.   C/EBP beta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma
  2. Mantena, S. R.; Kannan, A.; Cheon, Y. P.; Li, Q. X.; Johnson, P. F.; Bagchi, I. C.; Bagchi, M. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, FEB 7; 103(6): 1870-1875.
  1. 7.   Comparison of the NO and HNO donating properties of diazeniumdiolates: Primary amine adducts release HNO in vivo
  2. Miranda, K. M.; Katori, T.; de Holding, C. L. T.; Thomas, L.; Ridnour, L. A.; MeLendon, W. J.; Cologna, S. M.; Dutton, A. S.; Champion, H. C.; Mancardi, D.; Tocchetti, C. G.; Saavedra, J. E.; Keefer, L. K.; Houk, K. N.; Fukuto, J. M.; Kass, D. A.; Paolocci, N.; Wink, D. A.
  3. Journal of Medicinal Chemistry. 2005, DEC 29; 48(26): 8220-8228.
  1. 8.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 9.   A new synthetic agent with potent but selective cytotoxic activity against cancer
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Hollingshead, M. G.; Hariprakasha, H. K.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2005, JUN 30; 48(13): 4474-4481.
  1. 10.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 11.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 12.   Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis
  2. Beltz, H.; Clauss, C.; Piemont, E.; Ficheux, D.; Gorelick, R. J.; Roques, B.; Gabus, C.; Darlix, J. L.; de Rocquigny, H.; Mely, Y.
  3. Journal of Molecular Biology. 2005, MAY 20; 348(5): 1113-1126.
  1. 13.   Qualitative assessment Of IC50 values of inhibitors of the neuronal nicotinic acetylcholine receptor using a single chromatographic experiment and multivariate cluster analysis
  2. Jozwiak, K.; Moaddel, R.; Yamaguchi, R.; Ravichandran, S.; Collins, J. R.; Wainer, I. W
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2005, MAY 5; 819(1): 169-174.
  1. 14.   Conditional alleles for activation and inactivation of the mouse Rx homeobox gene
  2. Voronina, V. A.; Kozlov, S.; Mathers, P. H.; Lewandoski, M.
  3. Genesis. 2005, APR; 41(4): 160-164.
  1. 15.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 16.   Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines
  2. Simoni, D.; Grisolia, G.; Giannini, G.; Roberti, M.; Rondanin, R.; Piccagli, L.; Baruchello, R.; Rossi, M.; Romagnoli, R.; Invidiata, F. P.; Grimaudo, S.; Jung, M. K.; Hamel, E.; Gebbia, N.; Crosta, L.; Abbadessa, V.; Di Cristina, A.; Dusonchet, L.; Meli, M.; Tolomeo, M.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 723-736.
  1. 17.   Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics
  2. Sun, H. Y.; Nikolovska-Coleska, Z.; Chen, J. Y.; Yang, C. Y.; Tomita, Y.; Pan, H. G.; Yoshioka, Y.; Krajewski, K.; Roller, P. P.; Wang, S. M.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, FEB 1; 15(3): 793-797.
  1. 18.   Efficient and precise measurement of H-alpha-C-alpha, C-alpha-C ', C-alpha-C-beta and H-N-N residual dipolar couplings from 2D H-N-N correlation spectra
  2. McFeeters, R.; Fowler, C.; Gaponenko, V.; Byrd, R.
  3. Journal of Biomolecular Nmr. 2005, JAN; 31(1): 35-47.
  1. 19.   Effect of cell cycle inhibition on cisplatin-induced cytotoxicity
  2. Fishel, M. L.; Newell, D. R.; Griffin, R. J.; Davison, R.; Wang, L. Z.; Curtin, N. J.; Zuhowski, E. G.; Kasza, K.; Egorin, M. J.; Moschel, R. C.; Dolan, M. E.
  3. Journal of Pharmacology and Experimental Therapeutics. 2005, JAN; 312(1): 206-213.
  1. 21.   Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization
  2. Edsall, A. B.; Mohanakrishnan, A. K.; Yang, D. L.; Fanwick, P. E.; Hamel, E.; Hanson, A. D.; Agoston, G. E.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5126-5139.
  1. 22.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
  1. 23.   Anti-HIV cyclotides
  2. Gustafson, K. R.; McKee, T. C.; Bokesch, H. R.
  3. Current Protein & Peptide Science. 2004, OCT; 5(5): 331-340.
  1. 24.   Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C)
  2. Tamamura, H.; Sigano, D. M.; Lewin, N. E.; Peach, M. L.; Nicklaus, M. C.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, SEP 23; 47(20): 4858-4864.
  1. 25.   PAR-1 for the course of neurodegeneration
  2. Fortini, M. E.
  3. Cell. 2004 116(5): 631-632.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel